Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Short Term Feeding for Asian Patients With Liver Cirrhosis

This study has been completed.
Information provided by:
University of Malaya Identifier:
First received: July 16, 2010
Last updated: February 27, 2011
Last verified: July 2010
The benefits of short-term naso-gastric feeding in patients with advanced cirrhosis remain uncertain. This was a randomised study comparing naso-gastric feeding and oral feeding in Asian patients with cirrhosis who were admitted to hospital for decompensation.

Condition Intervention
Dietary Supplement: Osmolite and B.C.A.A.
Dietary Supplement: Normal oral intake & supplementation if necessary

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Short Term Feeding for Hospitalised Asian Patients With Liver Cirrhosis - a Randomised Trial of Naso-gastric vs Oral Feeding

Resource links provided by NLM:

Further study details as provided by University of Malaya:

Primary Outcome Measures:
  • Improvement in Child-Pugh score [ Time Frame: Up to 6 weeks ]
    Change in the Child-Pugh score, assessing liver damage in cirrhosis

Secondary Outcome Measures:
  • Improvement in nutritional parameters [ Time Frame: up to 6 weeks ]
    Improvement in nutritional anthropometry and assessment tool markers after intervention

Enrollment: 52
Study Start Date: March 2008
Study Completion Date: May 2010
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Naso-gastric tube feeding Dietary Supplement: Osmolite and B.C.A.A.
Feeding inserted into enteral tubes
Other Name: Enteral supplementation
Active Comparator: Oral feeding Dietary Supplement: Normal oral intake & supplementation if necessary
Enteral nutrition
Other Name: Enteral supplementation

Detailed Description:
Consecutive patients with decompensated cirrhosis who fitted the inclusion criteria, will be randomised to either naso-gastric or oral feeding. Total feeding will be for 2 weeks only. Following intervention specific nutritional and liver-related parameters will be measured during the 2 weeks and up to 6 weeks later. Comparison between both groups will then be made.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with decompensated cirrhosis of any etiology.

Exclusion Criteria:

  • Advanced hepatic encephalopathy,
  • Variceal bleeding,
  • Hepatocellular carcinoma.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01165073

University of Malaya Medical Centre
Kuala Lumpur, Federal Territory, Malaysia, 59100
Sponsors and Collaborators
University of Malaya
Study Director: Sanjiv Mahadeva, MRCP University of Malaya
Principal Investigator: Mei-Ling S Tai, MRCP University of Malaya
  More Information

Responsible Party: Dr Sanjiv Mahadeva/ Dr Sharon Tai Mei Ling, University of Malaya Identifier: NCT01165073     History of Changes
Other Study ID Numbers: NGVOC1
Study First Received: July 16, 2010
Last Updated: February 27, 2011

Keywords provided by University of Malaya:
Enteral nutrition

Additional relevant MeSH terms:
Liver Cirrhosis
Pathologic Processes
Liver Diseases
Digestive System Diseases processed this record on April 28, 2017